the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
November 02, 2024 – In the popular press and with people of public interest and fame in the weightloss and beauty industries, Semaglutide has been considered the slimming miracle elixir par excellence. Wegovy, Rybelsus, and Ozempic, all of which are based on …
Semagludite: The cause for NAION and Blood Clots? Read more »
26 May 2024 – Semaglutide is the active ingredient in the three Novo Nordisk drugs Ozempic, Rybelsus, and Wegovy that are being used for weight loss purposes. Thus, Ozempic, which was approved in 2017 by the FDA as a Type 2 diabetes treatment, …
Severe Stomach Conditions in Patients taking Semaglutide Read more »
December 11, 2023 – In June of 2021, the American Food and Drug Administration (FDA) approved the drug semaglutide for chronic weight management under the brand name Wegovy, ushering in a new era of obesity treatment. Since then, demand for …
Semaglutide Popularity: Serious Rare Adverse Effects Are Emerging Read more »
August 04, 2023 – We at thasso recently had an article (blog) on the much discussed and recently throughout the social media as wonder compound (drug) for weight loss promoted active ingredient Semaglutide in the form of the newly marketed product …
Is there living pharmacogenovigilance behind Semaglutide drugs? Read more »
July 16, 2023 – For months, it has been considered the slimming miracle elixir: the pharmac0logically active ingredient Semaglutide. Semaglutide is a GLP-1 receptor agonist, which means it mimics the action of human incretin glucagon-like peptide-1 (GLP-1). This improves insulin …